Compare PRK & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PRK | HTFL |
|---|---|---|
| Founded | 1908 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | 1996 | N/A |
| Metric | PRK | HTFL |
|---|---|---|
| Price | $184.58 | $26.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $184.00 | $38.20 |
| AVG Volume (30 Days) | 102.5K | ★ 2.1M |
| Earning Date | 04-24-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | ★ 19.21 | N/A |
| EPS | ★ 2.39 | N/A |
| Revenue | ★ $664,421,000.00 | N/A |
| Revenue This Year | $24.26 | $27.66 |
| Revenue Next Year | $3.63 | $23.55 |
| P/E Ratio | $76.51 | ★ N/A |
| Revenue Growth | ★ 2.92 | N/A |
| 52 Week Low | $149.06 | $20.13 |
| 52 Week High | $188.04 | $41.22 |
| Indicator | PRK | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 60.16 | 39.35 |
| Support Level | $165.30 | $24.77 |
| Resistance Level | $188.04 | $32.69 |
| Average True Range (ATR) | 3.73 | 2.33 |
| MACD | -0.10 | -0.82 |
| Stochastic Oscillator | 73.62 | 8.73 |
Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. The company provides the following principal services: the acceptance of deposits for demand, savings and time accounts; commercial, industrial, consumer and real estate lending, including installment loans, credit cards (which are largely offered through a third party), home equity lines of credit and commercial leasing; trust and wealth management services; cash management; safe deposit operations; electronic funds transfers; and a variety of additional banking-related services.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.